Michael Surette

Michael Surette is a Professor in the Department of Medicine at McMaster University. His research focuses on microbiota and host-microbiome interactions in health and disease, particularly in cystic fibrosis, inflammatory bowel disease, and immune-mediated disorders. He has contributed to understanding the role of gut microbiota in conditions like Crohn's disease, ulcerative colitis, and Parkinson's disease models. His work integrates molecular microbiology, genomics, and clinical epidemiology to explore microbial contributions to human health.

Educations and affiliations: Ph.D. in Microbiology (university unspecified), affiliated with McMaster's Institute of Infectious Disease Research and the Michael G. DeGroote Institute for Infectious Disease Research.

Research interests include microbial pathogenesis, antibiotic resistance, and translational applications of microbiome research. His team investigates how microbial communities influence disease outcomes, such as in cystic fibrosis lung infections and gut-brain axis interactions. He has pioneered methods like culture-enriched metagenomics to better profile microbial communities.

Publications span microbiology, immunology, and clinical gastroenterology, with emphasis on probiotics, fecal microbiota transplantation, and microbial biomarkers for disease prediction. Awards include recognition in microbiome research (specific prizes not listed).

Grants and collaborations: Multiple grants supporting studies on microbiome dynamics in chronic diseases. Advises graduate students and postdocs in microbiology and immunology. Lab focuses on translational research in microbial therapies and diagnostics.

Labs/teams: Leads the Surette Lab at McMaster, collaborating with clinical teams to advance microbiome-based interventions for gastrointestinal and respiratory diseases.